2015, Number 3
<< Back
Arch Neurocien 2015; 20 (3)
Multifocal motor neurophaty: report of 5 cases in western Mexico
Estrada VNA
Language: English
References: 24
Page: 227-230
PDF size: 112.93 Kb.
ABSTRACT
Multifocal motor neuropathy is an entity with epidemiological, clinical and neurophysiological features. We describe
a series of five patients with early asymmetrical limb weakness, progressive clinical course and nerve conduction
studies showing motor conduction blocks. All patients had a good response to immunotherapy; interestingly this
response had wide discrepancy. One patient had a clinical course of only 2 years with no improvement to
immunotherapy and other with 12 years of evolution had a good clinical response. Neurophysiological studies showed
only diagnostic implication and no change all over the time. This series suggest that multifocal motor neuropathy
has consistency in its epidemiological description, with female predominant, clinical response to immunoglobulin,
however this response is not conditioned to time between symptom beginning and time of diagnosis.
REFERENCES
Léger J. Multifocal motor neuropathy with persisten conduction blocks:18 years on. Rev Neurol (Paris). 2004;160:889-98.
Miyashiro A, Matsui N, Shimatani Y, Nodera H, Izumi Y, Kuwabara S Et al. Are multifocal motor neuropathy patients underdiagnosed? An epidemiological survey in Japan. Musle Nerve 2014; 49: 357-61.
Nobile E. Multifocal motor neuropathy. J Neuroimmunology 2001;115:4-18.
Londono X, Lewis R. Multifocal Motor Neuropathy. En Handbook of clinical neurology 3rd series. United States of America. Elsevier 2013:429-31.
Furukawa T, Matsui N, Fujita K, Miyashiro A, Nodera H, Izumi Y et al Increased proinflammatory cytokines in sera of patients with multifocal motor neuropathy. J Neruol Sci 2014;346:75- 79.
Breiner A, Barnett C, Vera B. INCAT disability score: a critical analysis of its measurement properties. Muscle & Nerve 2014;50:164-9.
Lawson V, Arnold D. Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment. Neuropsychiatric Disease and Treatment 2014; 10:567-76.
Nobile-Orazio E, Giannotta C, Musset L, Messina P, Léger J. Sensitivity and predictive value of anti GM1/ galactocerebroside igM antibodies in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 2014; 85: 754-8.
European Federation of Neurological Societies/Peripheral Nerve Society Guideline( on management of multifocal motor neuropathy. Report of a joint task force of the european federation of neurological societies and the peripheral nerve Society -first revision-. Journal of The Peripheral Nervous System 2010;15:295-301.
Meuth S, Kleinschnitz C. Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options. Eur Neurol 2010;63:193-204.
Censo de población. Guadalajara, Jalisco Instituto nacional de estadística y geografía. Censo de población 2010.
Eldar AH, Chapman J. Guillain Barre synbdrome and other immune mediated neuropathies: diagnosis and classification. Autoimmun Rev 2014;13:525-30.
Geevasinga N, Day B, Ng K. Multifocal motor neuropathy with muscle hypertrophy. Interna Med J 2013; 43:1237-9.
Hahn A, Bevdoun S, Lawson V, Oh M, Empsom V, Leibi H, et al. A controlled trial of intravenous inmunoglobulin in multifocal motor neuropathy. J Peripher Nerv Syst 2013;18:321-30.
Lotte V, Leonard H, Van den B, Cats E, Sanne P, Van der Pol L. Inmune pathogenesis and treatment of multifocal motor neuropathy. J Clin Immunol 2013; 33:S38-S42.
Svennerholm L, Boström K, Fredman P, Jungbjer B, Lekman A, Mansson J, et al. Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. Biochimica et biophysica Acta 1994;1214:115-123.
Adams D, Kuntzer T, Burger D, Chofflon M, Magistris M, Regli F et al. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol 1991;32:223-30.
Van Asseldonk AT, Franssen H, Van den Berg-Vos R, Wokke J, Van den Berg L. Multifocal motor neuropathy. Lancet Neurol 2005;4:309-319.
Niebroj-Bodosz I, Janik P, Kwiecinski H. Serum igM anti-GM1 ganglioside antibodies in lower motor neuron syndromes. Eur J Neurol 2000;11:13-6.
Franseen H, Straver D. Pathophysiology of immune-mediated demyelinating neuropathies-part II: neurology. Muscle Nerve 2014;494-20.
Dale J, Rajwinder N, Voustianiouk A, Seidel G. Panchal J, et al. Do A-waves help predict intravenous immunoglobulin response in multifocal motor neuropathy without block?
Simon NG, Gretchen A, Lomen-Hoerth C. Is IV therapy warranted in progressive lovwer motor neuron syndromes without conduction block?. Neurology 2013;10;81:2116-20.
Rigamonti A, Lauria G, Stanzani L, Piamarta F, Agostoni E. A case of multifocal motor neuropathy with conduction block associated with gastric and lung adenocarcinoma.
Stern B, Baehring J, Kleopa K, Hochberg F. Multifocal motor neuropathy with conduction block associated with metastatic lymphoma of the ner vous system. J Neuro-oncology 2006;78:81-4.